- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2005-004247-54.
Displaying page 1 of 1.
EudraCT Number: 2005-004247-54 | Sponsor Protocol Number: D6997C00006 (9238IL/0068) | Start Date*: 2006-04-05 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Randomised, Double-blind, Parallel-group, Multicentre, Phase II Study to Evaluate the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 250 mg, Fulvestrant (FASLODEX™) 250 mg (plus 250 mg Load... | ||
Medical condition: Postmenopausal women with oestrogen receptor (ER) positive advanced breast cancer who have either relapsed whilst on adjuvant endocrine therapy, or progressed whilst on first endocrine therapy for ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Completed) HU (Completed) CZ (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
